⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23926891 | 1.00 | — | — | |
| SCHEMBL7251954 | 1.00 | ALDH1A1 (0.64) | — | |
| SCHEMBL8070566 | 1.00 | ALDH1A1 (0.64) | — | |
| SCHEMBL210674 | 1.00 | ALDH1A1 (0.64) | — | |
| SCHEMBL7251951 | 1.00 | ALDH1A1 (0.64) | — | |
| SCHEMBL6685389 | 0.95 | ALDH1A1 (0.58) | — | |
| SCHEMBL2978854 | 0.95 | ALDH1A1 (0.58) | — | |
| SCHEMBL3423722 | 0.95 | ALDH1A1 (0.58) | — | |
| SCHEMBL25426745 | 0.95 | — | — | |
| SCHEMBL19866588 | 0.95 | ALDH1A1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2478 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122218-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2025-04-17 | — | — | US | claimed |
| EP-4476230-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2024-12-18 | — | — | EP | claimed |
| EP-3986552-B1 | ISOXAZOLE CARBOXYLIC ACIDS AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2024-09-18 | — | — | EP | claimed |
| WO-2023154291-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | claimed |
| CN-109689848-B | Fragrance composition | 奇华顿股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-115216178-A | Ink composition for OLED packaging and preparation method thereof | 西安思摩威新材料有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114907341-A | Pyridopyrimidinone derivatives, and preparation method and application thereof | 武汉人福创新药物研发中心有限公司 | 2022-08-16 | — | — | CN | claimed |
| EP-2744771-B1 | C-HALOGEN BOND FORMATION | UNIV PRINCETON (US) | 2020-10-21 | — | — | EP | claimed |
| US-20200190012-A1 | C-HALOGEN BOND FORMATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2020-06-18 | — | — | US | claimed |
| EP-3642264-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | Momentive Performance Materials Inc. (US) | 2020-04-29 | — | — | EP | claimed |
| US-5847246-A | Fluid heat transfer medium and heat transfer process | Loikits, Daniel J. (US) | 1998-12-08 | — | — | US | claimed |
| EP-0775123-B1 | SACCHARIN DERIVATIVES | BASF AG (DE) | 1998-09-30 | — | — | EP | claimed |
| US-5744425-A | POSTEMERGENCE, PREEMERGENCE HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | claimed |
| WO-1998012156-A1 | COMBINATORIAL APPROACH FOR GENERATING NOVEL COORDINATION COMPLEXES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-03-26 | — | — | WO | claimed |
| WO-1997008116-A1 | FLUID HEAT TRANSFER MEDIUM AND HEAT TRANSFER PROCESS | LOIKITS INDUSTRIAL SERVICES (US) | 1997-03-06 | — | — | WO | claimed |
| EP-0714302-A4 | THERAPEUTIC COMPOUNDS | CELL THERAPEUTICS INC (US) | 1996-10-09 | — | — | EP | claimed |
| EP-0714302-A1 | THERAPEUTIC COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1996-06-05 | — | — | EP | claimed |
| WO-1994024133-A1 | RING-SUBSTITUTED CELL SIGNALING INHIBITORS | CELL THERAPEUTICS, INC. (US) | 1994-10-27 | — | — | WO | claimed |
| WO-1994022449-A1 | THERAPEUTIC COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-10-13 | — | — | WO | claimed |
| US-4327232-A | Cyclopropane ring-containing compounds as inhibitor components in methylchloroform | THE DOW CHEMICAL COMPANY (US) | 1982-04-27 | — | — | US | claimed |